Delivery of biologically active polypeptides
OwnerLothar Steidler, Erik Remaut +2inventors
InventorsLothar Steidler, Erik Remaut, Jeremy Mark Wells, Richard William Falla Le Page
Life of this patent
Estimating the term…
Abstract
Biologically active polypeptides and/or antigens are delivered by administering to a subject a non-invasive or non-pathogenic bacterium which expresses one or more antigens or polypeptides. The non-invasive or non-pathogenic bacterium can be included in delivery systems or pharmaceutical formulations.
Claims43
A method of delivering one or more antigens or biologically active polypeptides to a subject in need of same which comprises administering to the subject a non-invasive or non-pathogenic bacterium which expresses the one or more antigens or polypeptides.
A pharmaceutical formulation comprising a non-invasive or non-pathogenic bacterium having a nucleic acid construct or vector comprising one or more constitutive promoters and coding sequences for the expression of one or more antigens and/or heterologous biologically active polypeptides, and one or more pharmaceutically acceptable excipients, adjuvants, buffers, stabilizers or carriers.
Nucleic acid comprising one or more coding sequences for one or more biologically active polypeptides and one or more coding sequences for one or more antigens wherein each coding sequence is under the control of a promoter for expression in a non-invasive or non-pathogenic bacterium.
A non-invasive or non-pathogenic bacterium expressing (i) one or more heterologous biologically active polypeptides and (ii) one or more antigens.
Dependencies are inferred from the claim text.